| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e589439ebdcd68a5d8ffa0062e8a2a33 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-163
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00 |
| filingDate |
2000-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f71ebe9c8f1a8197f75bc489afaa11fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_472b419e6643b58defbf2b7ef958aeca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31ee931c094fdada9a51b874ad860e1d |
| publicationDate |
2006-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6984486-B1 |
| titleOfInvention |
Synthetic peptide of regulatory virus protein R (VPR) of human immunodeficiency virus type 1 (HIV-1) and the utilization thereof |
| abstract |
The invention pertains to synthetic (s) peptides derived from the viral regulatory protein R (Vpr) of the human immunodeficiency virus type 1 (HIV-1), particularly the chemical synthesis of the 96 amino acid full length Vpr protein (sVpr 1-96 ), of a 47 amino acid long N-terminal (sVpr 1-47 ), of a 49 amino acid long C-terminal fragment (sVpr 48-96 ) as well as fragments thereof (sVpr 1-20 and sVpr 21-40 ) and further approximately 15 amino acid long fragments of sVpr 1-96 . As fragments or full length products of the HIV-1 regulatory protein, those products are used in biological assays, for molecular and structural characterization of Vpr and domains thereof, as well as for the development of anti-Vpr antibodies directed against Vpr peptide sequences. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077545-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7264808-B2 |
| priorityDate |
1999-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |